Bafna Pharmaceuticals Ltd.
BAFNAPH
Bafna Pharmaceuticals Ltd. Share Price
156.79 0.00 (0.00%)Fundamentals
Market Cap₹353Cr | EPS₹4.69 |
Book Value/Share₹40.64 | P/E Ratio (TTM)31.84 |
Industry P/E (TTM)40.29 | P/B Ratio4.16 |
Long Term D/E0.38 | ROE12.26% |
Dividend Yield (TTM)0.00% |
Analysis
Overview
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Huge Underperformer
Good Quality
High Price Fluctuation
Peer Comparison
Peer comparison lists companies from the same sector, scored and ranked based on Crisp Analysis. It helps understand how a company stands against its competitors.
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Bafna Pharmaceuticals Ltd.
What is the share price of Bafna Pharmaceuticals Ltd.?
The share price of Bafna Pharmaceuticals Ltd. is ₹156.79 on NSE as of 18/6/2026, 7:39:57 am. Share prices may change frequently due to market movements.
What is the market capitalisation of Bafna Pharmaceuticals Ltd.?
The market capitalisation of Bafna Pharmaceuticals Ltd. is ₹353Cr as of 18/6/2026, 7:39:57 am
What is the current P/E ratio of Bafna Pharmaceuticals Ltd.?
The current Price to Earnings (P/E) ratio of Bafna Pharmaceuticals Ltd. is 31.84 as of 18/6/2026, 7:39:57 am
What is the current P/B ratio of Bafna Pharmaceuticals Ltd.?
The Price to Book (P/B) ratio of Bafna Pharmaceuticals Ltd. stands at 4.17 as of 18/6/2026, 7:39:57 am
What is the ROE of Bafna Pharmaceuticals Ltd.?
Bafna Pharmaceuticals Ltd. reported an ROE of 12.27% for the last reported financial year on a consolidated account basis.
What is the shareholding pattern of Bafna Pharmaceuticals Ltd.?
As of 18/6/2026, 7:39:57 am, Bafna Pharmaceuticals Ltd.’s shareholding pattern is: promoters hold 75.00%, FIIs hold 9.30%, DIIs hold 0.00%, and public shareholders hold 15.70%.
What is the 52-week high and low of Bafna Pharmaceuticals Ltd.?
The 52-week high of Bafna Pharmaceuticals Ltd. is ₹156.79 and the 52-week low is ₹144.01 as of 18/6/2026, 7:39:57 am.
What is the EPS of Bafna Pharmaceuticals Ltd.?
The earnings per share (EPS) of Bafna Pharmaceuticals Ltd. is ₹1.16 for the quarter ended Mar 2026.
What is the stock symbol of Bafna Pharmaceuticals Ltd.?
The stock symbol of Bafna Pharmaceuticals Ltd. is BAFNAPH.
How to buy Bafna Pharmaceuticals Ltd.?
You can buy Bafna Pharmaceuticals Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
What is the fair value of Bafna Pharmaceuticals Ltd.?
The fair value of Bafna Pharmaceuticals Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Mar 2026 | Q/Q Change |
|---|---|---|
| Operating Revenue | 42.24 | +10.32% |
| Other Income | 1.76 | +44.26% |
| Total Income | 44.00 | +11.36% |
| Total Expenditure | 38.69 | +9.79% |
| EBIDT | 5.31 | +24.36% |
| Depreciation | 1.66 | +5.73% |
| Interest | 1.03 | +19.77% |
| Tax | -0.13 | - |
| Net Profit | 2.75 | +49.46% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 89.65 |
| Total Non-Current Assets | 85.88 |
| Fixed assets | 84.92 |
| Total Assets | 175.53 |
| Total Current liabilities | 57.19 |
| Total Non Current Liabilities | 22.19 |
| Total Equity Plus Liabilities | 175.53 |
| Total Shareholder Funds | 96.15 |
| Total Debt to Equity | 39.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 15.37 |
| Cash from Financing Activities | 5.62 |
| Cash from Investing Activities | -22.40 |
| Net Cash Flow | -1.41 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages8
Bearish Moving Averages8
5 Day
162.4010 Day
167.0020 Day
151.3030 Day
145.6050 Day
139.70100 Day
127.10150 Day
136.30200 Day
136.30Indicators
RSI (14)
49.23MACD (12, 26)
8.07MACD Signal Line (9)
8.64MFI (14)
39.73ATR (14)
10.90ADX (14)
33.28ROC (21)
10.37ROC (125)
6.70Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 149.33 | 149.33 | 149.33 | 149.33 | 149.33 | 149.33 | 149.33 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Bafna Pharmaceuticals Ltd.
BAFNAPH
Open Price | 144.01 |
Prev Close | 156.79 |
Upper Circuit | 164.62 |
Lower Circuit | 148.96 |
Volume | 51,020 |
Average Traded Price | 151.62 |
Historical Performance
| 1 Day | NA |
| 5 Days | NA |
| 1 Month | NA |
| 3 Months | NA |
| 1 Year | NA |
| 5 Years | NA |
| 10 Years | NA |